{"transactions":[{"id":1763585,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-10-06T18:24:28.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":4016,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU (as defined in footnote 6 to the Form 4) represents a contingent right to receive one Ordinary Share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Reflects the disposition of Issuer's restricted stock unit awards (each, a \"RSU\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding RSU (whether or not vested) was  canceled and converted into the right to receive a cash amount equal to (i) the total number of Ordinary Shares subject to such RSU multiplied by (ii) the Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Ordinary Shares subject to the RSUs vest on July 27, 2024."}],"balance_after":0,"derivative":{"expiration_date":"2024-07-27","underlying":"Ordinary Shares","underlying_shares":4016},"source":{"system":"sec-edgar","filing":"0001209191-23-052376","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123052376/doc4.xml","form_type":"4"}},{"id":1763584,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-10-06T18:24:28.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10838,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the disposition of Issuer's options to purchase Ordinary Shares (each, an \"Option\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding Option (whether or not vested) was canceled and converted into the right to receive cash, without interest, in an amount equal to (a) the total number of Ordinary Shares subject to such Option, multiplied by (b) the excess of (i) the Consideration over (ii) the exercise price payable per Ordinary Share under such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Option (as defined in footnote 3 to this Form 4) is fully vested."}],"balance_after":0,"derivative":{"exercise_price":13.87,"expiration_date":"2028-05-02","underlying":"Ordinary Shares","underlying_shares":10838},"source":{"system":"sec-edgar","filing":"0001209191-23-052376","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123052376/doc4.xml","form_type":"4"}},{"id":1763583,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-10-06T18:24:28.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":31153,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the disposition of Issuer's options to purchase Ordinary Shares (each, an \"Option\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding Option (whether or not vested) was canceled and converted into the right to receive cash, without interest, in an amount equal to (a) the total number of Ordinary Shares subject to such Option, multiplied by (b) the excess of (i) the Consideration over (ii) the exercise price payable per Ordinary Share under such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Option (as defined in footnote 3 to this Form 4) is fully vested."}],"balance_after":0,"derivative":{"exercise_price":15.12,"expiration_date":"2027-05-02","underlying":"Ordinary Shares","underlying_shares":31153},"source":{"system":"sec-edgar","filing":"0001209191-23-052376","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123052376/doc4.xml","form_type":"4"}},{"id":1763582,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-10-06T18:24:28.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":23092,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the disposition of Issuer's options to purchase Ordinary Shares (each, an \"Option\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding Option (whether or not vested) was canceled and converted into the right to receive cash, without interest, in an amount equal to (a) the total number of Ordinary Shares subject to such Option, multiplied by (b) the excess of (i) the Consideration over (ii) the exercise price payable per Ordinary Share under such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Option (as defined in footnote 3 to this Form 4) is fully vested."}],"balance_after":0,"derivative":{"exercise_price":15.23,"expiration_date":"2026-05-02","underlying":"Ordinary Shares","underlying_shares":23092},"source":{"system":"sec-edgar","filing":"0001209191-23-052376","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123052376/doc4.xml","form_type":"4"}},{"id":1763581,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-10-06T18:24:28.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":8548,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the disposition of Issuer's options to purchase Ordinary Shares (each, an \"Option\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding Option (whether or not vested) was canceled and converted into the right to receive cash, without interest, in an amount equal to (a) the total number of Ordinary Shares subject to such Option, multiplied by (b) the excess of (i) the Consideration over (ii) the exercise price payable per Ordinary Share under such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Option (as defined in footnote 3 to this Form 4) is fully vested."}],"balance_after":0,"derivative":{"exercise_price":28.53,"expiration_date":"2025-05-05","underlying":"Ordinary Shares","underlying_shares":8548},"source":{"system":"sec-edgar","filing":"0001209191-23-052376","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123052376/doc4.xml","form_type":"4"}},{"id":1763580,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-10-06T18:24:28.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10000,"price":116.5,"value":1165000.0,"ownership":{"direct":false,"nature":"By Family Limited Partnership"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the disposition of ordinary shares of Horizon Therapeutics plc (\"Issuer\"), nominal value $0.0001 per share (\"Ordinary Shares\"), in connection with the consummation of the transactions contemplated by the Transaction Agreement (the \"Transaction Agreement\"), dated as of December 11, 2022, by and among Issuer, Amgen Inc. (\"Parent\"), and Pillartree Limited, a wholly owned subsidiary of Parent (\"Acquirer Sub\"), including the consummation of a scheme of arrangement under Chapter 1 of Part 9 of the Companies Act 2014 of Ireland (the \"Scheme\") pursuant to which Acquirer Sub acquired Issuer. Pursuant to the Transaction Agreement, on October 6, 2023, the effective time of the Scheme (the \"Effective Time\"), each outstanding Ordinary Share was converted into $116.50 in cash (the \"Consideration\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-052376","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123052376/doc4.xml","form_type":"4"}},{"id":1763579,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-10-06T18:24:28.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":55953,"price":116.5,"value":6518524.5,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the disposition of ordinary shares of Horizon Therapeutics plc (\"Issuer\"), nominal value $0.0001 per share (\"Ordinary Shares\"), in connection with the consummation of the transactions contemplated by the Transaction Agreement (the \"Transaction Agreement\"), dated as of December 11, 2022, by and among Issuer, Amgen Inc. (\"Parent\"), and Pillartree Limited, a wholly owned subsidiary of Parent (\"Acquirer Sub\"), including the consummation of a scheme of arrangement under Chapter 1 of Part 9 of the Companies Act 2014 of Ireland (the \"Scheme\") pursuant to which Acquirer Sub acquired Issuer. Pursuant to the Transaction Agreement, on October 6, 2023, the effective time of the Scheme (the \"Effective Time\"), each outstanding Ordinary Share was converted into $116.50 in cash (the \"Consideration\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-052376","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123052376/doc4.xml","form_type":"4"}},{"id":1763578,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-10-06T18:24:28.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":110447,"price":116.5,"value":12867075.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the disposition of ordinary shares of Horizon Therapeutics plc (\"Issuer\"), nominal value $0.0001 per share (\"Ordinary Shares\"), in connection with the consummation of the transactions contemplated by the Transaction Agreement (the \"Transaction Agreement\"), dated as of December 11, 2022, by and among Issuer, Amgen Inc. (\"Parent\"), and Pillartree Limited, a wholly owned subsidiary of Parent (\"Acquirer Sub\"), including the consummation of a scheme of arrangement under Chapter 1 of Part 9 of the Companies Act 2014 of Ireland (the \"Scheme\") pursuant to which Acquirer Sub acquired Issuer. Pursuant to the Transaction Agreement, on October 6, 2023, the effective time of the Scheme (the \"Effective Time\"), each outstanding Ordinary Share was converted into $116.50 in cash (the \"Consideration\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-052376","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123052376/doc4.xml","form_type":"4"}},{"id":1770345,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-10-02T19:32:08.000Z","date":"2023-09-29","kind":"exercise","planned":false,"acquired":false,"shares":21323,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option is fully vested."}],"balance_after":10838,"derivative":{"exercise_price":13.87,"expiration_date":"2028-05-02","underlying":"Ordinary shares","underlying_shares":21323},"source":{"system":"sec-edgar","filing":"0001209191-23-051234","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123051234/doc4.xml","form_type":"4"}},{"id":1770344,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-10-02T19:32:08.000Z","date":"2023-09-29","kind":"exercise","planned":false,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":15.96,"expiration_date":"2024-06-26","underlying":"Ordinary shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-23-051234","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123051234/doc4.xml","form_type":"4"}},{"id":1770343,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-10-02T19:32:08.000Z","date":"2023-09-29","kind":"exercise","planned":false,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":12.29,"expiration_date":"2024-04-14","underlying":"Ordinary shares","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-23-051234","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123051234/doc4.xml","form_type":"4"}},{"id":1770342,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-10-02T19:32:08.000Z","date":"2023-09-29","kind":"exercise","planned":false,"acquired":true,"shares":21323,"price":13.87,"value":295750.01,"ownership":{"direct":true},"balance_after":110447,"source":{"system":"sec-edgar","filing":"0001209191-23-051234","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123051234/doc4.xml","form_type":"4"}},{"id":1770341,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-10-02T19:32:08.000Z","date":"2023-09-29","kind":"exercise","planned":false,"acquired":true,"shares":20000,"price":15.96,"value":319200.0,"ownership":{"direct":true},"balance_after":89124,"source":{"system":"sec-edgar","filing":"0001209191-23-051234","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123051234/doc4.xml","form_type":"4"}},{"id":1770340,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-10-02T19:32:08.000Z","date":"2023-09-29","kind":"exercise","planned":false,"acquired":true,"shares":40000,"price":12.29,"value":491600.0,"ownership":{"direct":true},"balance_after":69124,"source":{"system":"sec-edgar","filing":"0001209191-23-051234","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123051234/doc4.xml","form_type":"4"}},{"id":1821461,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-07-28T16:41:41.000Z","date":"2023-07-27","kind":"grant","planned":false,"acquired":true,"shares":4016,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":4016,"derivative":{"exercise_date":"2024-07-27","expiration_date":"2024-07-27","underlying":"Ordinary shares","underlying_shares":4016},"source":{"system":"sec-edgar","filing":"0001209191-23-043698","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123043698/doc4.xml","form_type":"4"}},{"id":1908232,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-05-02T19:32:40.000Z","date":"2023-04-28","kind":"exercise","planned":false,"acquired":false,"shares":3913,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":0,"derivative":{"exercise_date":"2023-04-28","expiration_date":"2023-04-28","underlying":"Ordinary Shares","underlying_shares":3913},"source":{"system":"sec-edgar","filing":"0001209191-23-026757","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123026757/doc4.xml","form_type":"4"}},{"id":1908231,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-05-02T19:32:40.000Z","date":"2023-04-28","kind":"exercise","planned":false,"acquired":true,"shares":3913,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"19,211 Ordinary Shares previously reported as indirectly held by Trust held directly."}],"balance_after":29124,"source":{"system":"sec-edgar","filing":"0001209191-23-026757","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123026757/doc4.xml","form_type":"4"}},{"id":2244038,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-03T16:31:07.000Z","date":"2022-06-02","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested in 12 equal monthly installments beginning on July 14, 2012."}],"balance_after":0,"derivative":{"exercise_price":4.15,"expiration_date":"2022-06-13","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-22-034062","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1307935/000120919122034062/doc4.xml","form_type":"4"}},{"id":2244037,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-03T16:31:07.000Z","date":"2022-06-02","kind":"sale","acquired":false,"shares":6441,"price":9.902,"value":63778.782,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's common stock sold to satisfy the exercise price of the stock options, which were scheduled to expire June 13, 2022 as reflected in this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.90 to $9.92, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":63064,"source":{"system":"sec-edgar","filing":"0001209191-22-034062","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1307935/000120919122034062/doc4.xml","form_type":"4"}},{"id":2244036,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-03T16:31:07.000Z","date":"2022-06-02","kind":"exercise","acquired":true,"shares":15000,"price":4.15,"value":62250.0,"ownership":{"direct":true},"balance_after":69505,"source":{"system":"sec-edgar","filing":"0001209191-22-034062","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1307935/000120919122034062/doc4.xml","form_type":"4"}},{"id":2286419,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-05-02T18:15:34.000Z","date":"2022-04-29","kind":"exercise","acquired":false,"shares":4223,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":0,"derivative":{"exercise_date":"2022-04-29","expiration_date":"2022-04-29","underlying":"Ordinary shares","underlying_shares":4223},"source":{"system":"sec-edgar","filing":"0001209191-22-026471","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919122026471/doc4.xml","form_type":"4"}},{"id":2286418,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-05-02T18:15:34.000Z","date":"2022-04-28","kind":"grant","acquired":true,"shares":3913,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":3913,"derivative":{"exercise_date":"2023-04-28","expiration_date":"2023-04-28","underlying":"Ordinary shares","underlying_shares":3913},"source":{"system":"sec-edgar","filing":"0001209191-22-026471","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919122026471/doc4.xml","form_type":"4"}},{"id":2286417,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-05-02T18:15:34.000Z","date":"2022-04-29","kind":"exercise","acquired":true,"shares":4223,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":75164,"source":{"system":"sec-edgar","filing":"0001209191-22-026471","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919122026471/doc4.xml","form_type":"4"}},{"id":2669836,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-14T16:37:34.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests and becomes exercisable with respect to 100% of the option shares on June 10, 2022, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date."}],"balance_after":10000,"derivative":{"exercise_price":19.21,"expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-040244","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1307935/000120919121040244/doc4.xml","form_type":"4"}},{"id":2669835,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-14T16:37:34.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 10, 2022, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date."}],"balance_after":54505,"source":{"system":"sec-edgar","filing":"0001209191-21-040244","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1307935/000120919121040244/doc4.xml","form_type":"4"}},{"id":2734469,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-04-30T19:01:21.000Z","date":"2021-04-30","kind":"exercise","acquired":false,"shares":11098,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":0,"derivative":{"exercise_date":"2021-04-30","expiration_date":"2021-04-30","underlying":"Ordinary shares","underlying_shares":11098},"source":{"system":"sec-edgar","filing":"0001209191-21-029365","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121029365/doc4.xml","form_type":"4"}},{"id":2734468,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-04-30T19:01:21.000Z","date":"2021-04-29","kind":"grant","acquired":true,"shares":4223,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":4223,"derivative":{"exercise_date":"2022-04-29","expiration_date":"2022-04-29","underlying":"Ordinary shares","underlying_shares":4223},"source":{"system":"sec-edgar","filing":"0001209191-21-029365","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121029365/doc4.xml","form_type":"4"}},{"id":2734467,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-04-30T19:01:21.000Z","date":"2021-04-30","kind":"exercise","acquired":true,"shares":11098,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":70941,"source":{"system":"sec-edgar","filing":"0001209191-21-029365","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121029365/doc4.xml","form_type":"4"}},{"id":2849280,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-18T20:43:49.000Z","date":"2021-02-16","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested in 12 equal monthly installments beginning on July 16, 2011."}],"balance_after":0,"derivative":{"exercise_price":7.11,"expiration_date":"2021-06-15","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-21-012205","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1307935/000120919121012205/doc4.xml","form_type":"4"}},{"id":2849279,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-18T20:43:49.000Z","date":"2021-02-16","kind":"sale","acquired":false,"shares":5818,"price":18.5383,"value":107855.8294,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's common stock sold to satisfy the exercise price of the stock options, which were scheduled to expire June 15, 2021 as reflected in this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.43 to $18.69, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":49505,"source":{"system":"sec-edgar","filing":"0001209191-21-012205","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1307935/000120919121012205/doc4.xml","form_type":"4"}},{"id":2849278,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-18T20:43:49.000Z","date":"2021-02-16","kind":"exercise","acquired":true,"shares":15000,"price":7.11,"value":106650.0,"ownership":{"direct":true},"balance_after":55323,"source":{"system":"sec-edgar","filing":"0001209191-21-012205","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1307935/000120919121012205/doc4.xml","form_type":"4"}},{"id":3110210,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-15T19:13:00.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests and becomes exercisable with respect to 100% of the option shares on June 11, 2021, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date."}],"balance_after":10000,"derivative":{"exercise_price":10.57,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-20-036787","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1307935/000120919120036787/doc4.xml","form_type":"4"}},{"id":3110209,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-15T19:13:00.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 11, 2021, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date."}],"balance_after":40323,"source":{"system":"sec-edgar","filing":"0001209191-20-036787","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1307935/000120919120036787/doc4.xml","form_type":"4"}},{"id":3126612,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (Right to Buy)","published_at":"2020-06-02T16:13:28.000Z","date":"2020-05-29","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested in 12 equal monthly installments beginning on July 3, 2010."}],"balance_after":0,"derivative":{"exercise_price":7.38,"expiration_date":"2020-06-02","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-20-033491","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1307935/000120919120033491/doc4.xml","form_type":"4"}},{"id":3126611,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-02T16:13:28.000Z","date":"2020-05-29","kind":"sale","acquired":false,"shares":9677,"price":11.5,"value":111285.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's common stock sold to satisfy the exercise price and certain tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the exercise of certain stock options, which were scheduled to expire June 2, 2020 as reflected in this Form 4."}],"balance_after":35323,"source":{"system":"sec-edgar","filing":"0001209191-20-033491","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1307935/000120919120033491/doc4.xml","form_type":"4"}},{"id":3126610,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-02T16:13:28.000Z","date":"2020-05-29","kind":"exercise","acquired":true,"shares":15000,"price":7.38,"value":110700.0,"ownership":{"direct":true},"balance_after":45000,"source":{"system":"sec-edgar","filing":"0001209191-20-033491","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1307935/000120919120033491/doc4.xml","form_type":"4"}},{"id":3163630,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-05-04T17:33:58.000Z","date":"2020-05-02","kind":"exercise","acquired":false,"shares":15390,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 2, 2019, the reporting person was granted 15,390 restricted stock units, vesting in full on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On May 2, 2019, the reporting person was granted 15,390 restricted stock units, vesting in full on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Ordinary shares","underlying_shares":15390},"source":{"system":"sec-edgar","filing":"0001209191-20-026893","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919120026893/doc4.xml","form_type":"4"}},{"id":3163629,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-05-04T17:33:58.000Z","date":"2020-04-30","kind":"grant","acquired":true,"shares":11098,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":11098,"derivative":{"exercise_date":"2021-04-30","expiration_date":"2021-04-30","underlying":"Ordinary shares","underlying_shares":11098},"source":{"system":"sec-edgar","filing":"0001209191-20-026893","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919120026893/doc4.xml","form_type":"4"}},{"id":3163628,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2020-05-04T17:33:58.000Z","date":"2020-05-02","kind":"exercise","acquired":true,"shares":15390,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":59843,"source":{"system":"sec-edgar","filing":"0001209191-20-026893","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919120026893/doc4.xml","form_type":"4"}},{"id":3487448,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-17T17:03:52.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests and becomes exercisable with respect to 100% of the option shares on June 13, 2020, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date."}],"balance_after":10000,"derivative":{"exercise_price":15.04,"expiration_date":"2029-06-12","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-19-037413","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1307935/000120919119037413/doc4.xml","form_type":"4"}},{"id":3487447,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-17T17:03:52.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU).  100% of the shares subject to this RSU will vest on June 13, 2020, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001209191-19-037413","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1307935/000120919119037413/doc4.xml","form_type":"4"}},{"id":3538038,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-05-06T17:51:29.000Z","date":"2019-05-03","kind":"exercise","acquired":false,"shares":15320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 3, 2018, the reporting person was granted 15,320 restricted stock units, vesting in full on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On May 3, 2018, the reporting person was granted 15,320 restricted stock units, vesting in full on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Ordinary shares","underlying_shares":15320},"source":{"system":"sec-edgar","filing":"0001209191-19-027821","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919119027821/doc4.xml","form_type":"4"}},{"id":3538037,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-05-06T17:51:29.000Z","date":"2019-05-02","kind":"grant","acquired":true,"shares":15390,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":15390,"derivative":{"exercise_date":"2020-05-02","underlying":"Ordinary shares","underlying_shares":15390},"source":{"system":"sec-edgar","filing":"0001209191-19-027821","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919119027821/doc4.xml","form_type":"4"}},{"id":3538036,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-05-06T17:51:29.000Z","date":"2019-05-03","kind":"tax_withholding","acquired":false,"shares":4132,"price":26.54,"value":109663.28,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":44453,"source":{"system":"sec-edgar","filing":"0001209191-19-027821","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919119027821/doc4.xml","form_type":"4"}},{"id":3538035,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-05-06T17:51:29.000Z","date":"2019-05-03","kind":"exercise","acquired":true,"shares":15320,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":48585,"source":{"system":"sec-edgar","filing":"0001209191-19-027821","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919119027821/doc4.xml","form_type":"4"}},{"id":3892210,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-15T16:30:26.000Z","date":"2018-06-13","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests and becomes exercisable with respect to 100% of the option shares on June 13, 2019, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date."}],"balance_after":10000,"derivative":{"exercise_price":18.3,"expiration_date":"2028-06-12","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-18-016767","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1307935/000089924318016767/doc4.xml","form_type":"4"}},{"id":3892209,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-15T16:30:26.000Z","date":"2018-06-13","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 13, 2019, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0000899243-18-016767","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1307935/000089924318016767/doc4.xml","form_type":"4"}},{"id":3944298,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-05-07T17:02:29.000Z","date":"2018-05-03","kind":"grant","acquired":true,"shares":15320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":15320,"derivative":{"exercise_date":"2019-05-03","underlying":"Ordinary shares","underlying_shares":15320},"source":{"system":"sec-edgar","filing":"0001209191-18-028361","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919118028361/doc4.xml","form_type":"4"}},{"id":3944297,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-07T17:02:29.000Z","date":"2018-05-03","kind":"grant","acquired":true,"shares":32161,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests in 12 equal monthly installments from the date of grant."}],"balance_after":32161,"derivative":{"exercise_price":13.87,"expiration_date":"2028-05-02","underlying":"Ordinary shares","underlying_shares":32161},"source":{"system":"sec-edgar","filing":"0001209191-18-028361","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919118028361/doc4.xml","form_type":"4"}},{"id":3944296,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-05-07T17:02:29.000Z","date":"2018-05-03","kind":"exercise","acquired":false,"shares":14054,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 3, 2017, the reporting person was granted 14,054 restricted stock units, vesting in full on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On May 3, 2017, the reporting person was granted 14,054 restricted stock units, vesting in full on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Ordinary shares","underlying_shares":14054},"source":{"system":"sec-edgar","filing":"0001209191-18-028361","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919118028361/doc4.xml","form_type":"4"}},{"id":3944295,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2018-05-07T17:02:29.000Z","date":"2018-05-03","kind":"exercise","acquired":true,"shares":14054,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":33265,"source":{"system":"sec-edgar","filing":"0001209191-18-028361","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919118028361/doc4.xml","form_type":"4"}},{"id":3945360,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-04T16:06:59.000Z","date":"2018-05-03","kind":"exercise","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vested in 12 equal monthly installments beginning on June 8, 2008."}],"balance_after":0,"derivative":{"exercise_price":4.98,"expiration_date":"2018-05-07","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000899243-18-011505","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1307935/000089924318011505/doc4.xml","form_type":"4"}},{"id":3945359,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-04T16:06:59.000Z","date":"2018-05-03","kind":"exercise","acquired":true,"shares":15000,"price":4.98,"value":74700.0,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0000899243-18-011505","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1307935/000089924318011505/doc4.xml","form_type":"4"}},{"id":4277152,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-19T17:11:30.000Z","date":"2017-06-15","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests and becomes exercisable with respect to 100% of the option shares on June 15, 2018, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date."}],"balance_after":10000,"derivative":{"exercise_price":13.75,"expiration_date":"2027-06-14","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-17-040883","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1307935/000120919117040883/doc4.xml","form_type":"4"}},{"id":4277151,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-19T17:11:30.000Z","date":"2017-06-15","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU).  100% of the shares subject to this RSU will vest on June 15, 2018, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001209191-17-040883","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1307935/000120919117040883/doc4.xml","form_type":"4"}},{"id":4333350,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-05-04T18:04:07.000Z","date":"2017-05-03","kind":"grant","acquired":true,"shares":14054,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":14054,"derivative":{"exercise_date":"2018-05-03","underlying":"Ordinary shares","underlying_shares":14054},"source":{"system":"sec-edgar","filing":"0001209191-17-030122","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919117030122/doc4.xml","form_type":"4"}},{"id":4333349,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-04T18:04:07.000Z","date":"2017-05-03","kind":"grant","acquired":true,"shares":31153,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests in 12 equal monthly installments from the date of grant."}],"balance_after":31153,"derivative":{"exercise_price":15.12,"expiration_date":"2027-05-02","underlying":"Ordinary shares","underlying_shares":31153},"source":{"system":"sec-edgar","filing":"0001209191-17-030122","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919117030122/doc4.xml","form_type":"4"}},{"id":4333348,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-05-04T18:04:07.000Z","date":"2017-05-03","kind":"exercise","acquired":false,"shares":13953,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 3, 2016, the reporting person was granted 13,953 restricted stock units, vesting in full on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On May 3, 2016, the reporting person was granted 13,953 restricted stock units, vesting in full on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Ordinary shares","underlying_shares":13953},"source":{"system":"sec-edgar","filing":"0001209191-17-030122","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919117030122/doc4.xml","form_type":"4"}},{"id":4333347,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":109162,"kind":"person","name":"Watkins Thomas","position":1,"cik":"0001307935","reported_name":"Watkins Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2017-05-04T18:04:07.000Z","date":"2017-05-03","kind":"exercise","acquired":true,"shares":13953,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":19211,"source":{"system":"sec-edgar","filing":"0001209191-17-030122","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919117030122/doc4.xml","form_type":"4"}}]}